Evidence map›Paper›PMID 29773702›Full record

ArticleBMJ open2018

Exploring variation in human papillomavirus vaccination uptake in Switzerland: a multilevel spatial analysis of a national vaccination coverage survey.

Maurane Riesen, Garyfallos Konstantinoudis, Phung Lang, Nicola Low, Christoph Hatz, Mirjam Maeusezahl, Anne Spaar, Marc Bühlmann, Ben D Spycher, Christian L Althaus

Abstract read
In one paragraph

Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maurane Riesen *Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0002-3460-1758
Garyfallos Konstantinoudis *Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Phung LangEpidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Nicola LowInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0003-4817-8986
Christoph HatzEpidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Mirjam MaeusezahlCommunicable Diseases, Swiss Federal Office of Public Health, Bern, Switzerland.
Anne SpaarCommunicable Diseases, Swiss Federal Office of Public Health, Bern, Switzerland.
Marc BühlmannInstitute of Political Science, University of Bern, Bern, Switzerland.
Ben D Spycher *Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Christian L Althaus *Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0002-5230-6760

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveUnderstanding the factors that influence human papillomavirus (HPV) vaccination uptake is critically important to the design of effective vaccination programmes. In Switzerland, HPV vaccination uptake (≥1 dose) by age 16 years among women ranges from 31% to 80% across 26 cantons (states). Our objective was to identify factors that are associated with the spatial variation in HPV vaccination uptake.

methodsWe used cross-sectional data from the Swiss National Vaccination Coverage Survey 2009-2016 on HPV vaccination status (≥1 dose) of 14-17-year-old girls, their municipality of residence and their nationality for 21 of 26 cantons (n=8965). We examined covariates at municipality level: language, degree of urbanisation, socioeconomic position, religious denomination, results of a vote about vaccination laws as a proxy for vaccine scepticism and, at cantonal level, availability of school-based vaccination and survey period. We used a series of conditional autoregressive models to assess the effects of covariates while accounting for variability between cantons and municipal-level spatial autocorrelation.

resultsIn the best-fit model, living in cantons that have school-based vaccination (adjusted OR 2.51; 95% credible interval 1.77 to 3.56) was associated with increased uptake, while living in municipalities with lower acceptance of vaccination laws was associated with lower HPV vaccination uptake (OR 0.61; 95% credible interval 0.50 to 0.73). Overall, the covariates explained 88% of the municipal-level variation in uptake.

conclusionsIn Switzerland, both cantons and community opinion about vaccination play a prominent role in the variation in HPV vaccination uptake. To increase uptake, efforts should be made to mitigate vaccination scepticism and to encourage school-based vaccination.

Indexed as

AdolescentCross-Sectional StudiesFemaleHumansImmunization ProgramsLogistic ModelsMultilevel AnalysisPapillomavirus InfectionsPapillomavirus VaccinesSchoolsSpatial AnalysisSurveys and QuestionnairesSwitzerlandVaccination CoveragePapillomavirus Vaccinesgeographical variationhuman papillomavirusinlaspatial analysisvaccinationvaccine scepticism

Identifiers

PMID29773702
PMCPMC5961588

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.